Retinoic Acid Binding Proteins and Cancer: Similarity or Polarity?

Elena M Tchevkina
Additional contact information
Elena M Tchevkina: Institute of Carcinogenesis, NN Blokhin National Medical Research Center of Oncology, Russia

Cancer Therapy & Oncology International Journal, 2017, vol. 8, issue 2, 31-35

Abstract: Vitamin A is a precursor for the multiple active metabolites, known as retinoids, among which retinoic acid (RA) is one of the most essential for the embryonic development as well as for the tissue maintenance and renewal in adults. RA upregulates the transcription factors that control the expression of a huge number of genes regulating differentiation, proliferation, cellular death and survival. Potent anticarcinogenic activity of RA has been repeatedly shown for several types of cancer cells. However, the implementation of RA as a therapeutic agent for cancer treatment is limited by the rapid acquisition of RA resistance. Moreover, in some type of tumors RA promotes rather than inhibits cell malignancy. One of the reasons for the development of RA resistance and such distinct functional significance of RA in carcinogenesis is attributed to the proteins, responsible for the delivery of RA to its nuclear receptors regulating transcription and intracellular signaling. The association with the different kind of RA binding proteins largely determines the future fate of RA and its intracellular activity.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555733.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555733.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:8:y:2017:i:2:p:31-35

DOI: 10.19080/CTOIJ.2017.08.555733

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().